Repligen Corp SEC filings RGEN
Repligen Corp has 1,003 filings in SEC EDGAR's recent list, going back to May 13, 2010. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (unregistered share sale, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 2, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 4, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 14, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Nov 18, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 1, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 11, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 22, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 17, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 26, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 1, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 22, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 23, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 25, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 17, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | Apr 8, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 14, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 15, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 15, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Jun 9, 2011 | Mar 31, 2011 |
| 10-K | Annual report | Jun 10, 2010 | Mar 31, 2010 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- RGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 730272
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.